Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Host-Associated Microbial Communities

The Cryptic Plasmid Improves Chlamydia Fitness in Different Regions of the Gastrointestinal Tract

Jingyue Ma, Conghui He, Zhi Huo, Ying Xu, Bernard Arulanandam, Quanzhong Liu, Guangming Zhong
Craig R. Roy, Editor
Jingyue Ma
aDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
bDepartment of Dermatovenereology, Tianjin Medical University General Hospital, Tianjin, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Conghui He
aDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi Huo
aDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying Xu
aDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard Arulanandam
cDepartment of Biology, University of Texas at San Antonio, San Antonio, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Quanzhong Liu
bDepartment of Dermatovenereology, Tianjin Medical University General Hospital, Tianjin, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guangming Zhong
aDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig R. Roy
Yale University School of Medicine
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.00860-19
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The cryptic plasmid is important for chlamydial colonization in the gastrointestinal tract. We used a combination of intragastric, intrajejunal, and intracolon inoculations to reveal the impact of the plasmid on chlamydial colonization in distinct regions of gastrointestinal tract. Following an intragastric inoculation, the plasmid significantly improved chlamydial colonization. At the tissue level, plasmid-positive Chlamydia produced infectious progenies throughout gastrointestinal tract. However, to our surprise, plasmid-deficient Chlamydia failed to produce infectious progenies in small intestine, although infectious progenies were eventually detected in large intestine, indicating a critical role of the plasmid in chlamydial differentiation into infectious particles in small intestine. The noninfectious status may represent persistent infection, since Chlamydia genomes proliferated in the same tissues. Following an intrajejunal inoculation that bypasses the gastric barrier, plasmid-deficient Chlamydia produced infectious progenies in small intestine but was 530-fold less infectious than plasmid-positive Chlamydia, suggesting that (i) the noninfectious status developed after intragastric inoculation might be induced by a combination of gastric and intestinal effectors and (ii) chlamydial colonization in small intestine was highly dependent on plasmid. Finally, following an intracolon inoculation, the dependence of chlamydial colonization on plasmid increased over time. Thus, we have demonstrated that the plasmid may be able to improve chlamydial fitness in different gut regions via different mechanisms, which has laid a foundation to further reveal the specific mechanisms.

INTRODUCTION

Sexually transmitted Chlamydia trachomatis may ascend to the upper genital tract to cause pathology, leading to hydrosalpinx and tubal infertility (1–3). However, the pathogenic mechanisms remain unclear. Chlamydia muridarum infection in the mouse genital tract has been used extensively for investigating the mechanisms of C. trachomatis pathogenesis (4–9), because mice intravaginally inoculated with C. muridarum consistently develop hydrosalpinx and infertility (10–12). Using this murine model, both chlamydial (13–17) and host (4, 8, 18–24) factors that affect C. muridarum induction of hydrosalpinx have been identified. The cryptic plasmid, termed pMoPn/pCM (25, 26), is a known pathogenic determinant of C. muridarum in the mouse upper genital tract (13, 16, 17, 27, 28). The plasmid codes 8 putative proteins designated plasmid-encoded glycoproteins 1 to 8 (pGP1 to -8) (25, 28, 29). While pGP3 may directly exert virulence functions (13), pGP4 (30, 31) and pGP5 (32) regulate other chlamydial genes.

C. trachomatis is also frequently detected in the human gastrointestinal (GI) tract (33–36). Interestingly, when C. muridarum was introduced to multiple mouse mucosae, it readily colonized the GI tract (37). The genital C. muridarum selectively spread to (38) and established long-lasting colonization in (38–40) the GI tract lumen. The C. muridarum spreading is likely via a hematogenous route (41). Although C. muridarum colonization in the GI tract is long lasting, it is nonpathological in the GI tract (42, 43). However, it was hypothesized that the GI C. muridarum might induce immune responses that may contribute to clinically relevant pathologies in the female reproductive tract (44). Nevertheless, C. muridarum is well adapted to the GI tract environment. Various C. muridarum virulence determinants identified in the genital tract were found to be important for C. muridarum colonization in the GI tract (44–49). Thus, evaluating the roles of chlamydial factors in C. muridarum colonization in the GI tract may provide biologically relevant information for understanding chlamydial pathogenic mechanisms in the genital tract.

We recently showed that plasmid-deficient C. muridarum exhibits significantly delayed/reduced colonization in mouse GI tract (45) and that C. muridarum lacking the plasmid-encoded pGP3 is rapidly cleared in the stomach (47, 49), indicating a critical role of the plasmid in protecting C. muridarum against gastric killing. However, it is still unknown whether and how the plasmid contributes to C. muridarum colonization in the remaining regions of the GI tract. The present study was designed to evaluate the role of plasmid in regulating chlamydial fitness in different regions of GI tract by using a combination of intragastric, intrajejunal, and intracolon inoculations. Following an intragastric inoculation, although plasmid-positive Chlamydia produced infectious progenies throughout the gastrointestinal tract, plasmid-deficient Chlamydia failed to produce any detectable infectious progenies in small intestine. To exclude an effect from the gastric barrier, we further used an intrajejunal inoculation to deliver chlamydial organisms into the lumen of small intestine and found that plasmid-deficient Chlamydia was able to produce infectious progenies but was 530-fold less infectious than plasmid-positive Chlamydia. These observations suggest that the noninfectious status developed after intragastric inoculation may be induced by a combination of gastric and intestinal effectors and that Chlamydia colonization in small intestine is highly dependent on plasmid. Following an intracolon inoculation, the plasmid also improved Chlamydia colonization, and the plasmid-dependent improvement became more obvious with a prolonged colonization time course. These observations have led us to propose that Chlamydia may have acquired the plasmid for improving its fitness in different regions of the GI tract via different mechanisms, since different regions of the GI tract are equipped with distinct host defense effector mechanisms (50–52).

RESULTS

Lack of plasmid significantly compromises chlamydial ability to colonize mouse gastrointestinal tract.We previously demonstrated that the cryptic plasmid, a known genital tract pathogenic virulence determinant, is more important for promoting chlamydial colonization in the gastrointestinal tract than in the genital tract (45, 47). Here, we further quantitatively titrated the role of the plasmid in promoting chlamydial colonization in the GI tract following an intragastric inoculation at various inoculation doses (Fig. 1). At an inoculation dose of 1,000 inclusion-forming units (IFU) per mouse, plasmid-positive Chlamydia established colonization in the GI tracts of 100% of the mice by day 7 and maintained a steady level of colonization thereafter, which is consistent with what we showed previously (42). However, plasmid-deficient Chlamydia was able to do so only at the inoculation dose of 1 × 105 IFU per mouse or higher. Moreover, even at high inoculation doses, colonization by plasmid-deficient Chlamydia was significantly delayed, and live organisms were only detectable in the rectal swabs by day 14. Thus, the cryptic plasmid improved chlamydial colonization in the GI tract by >100-fold.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Comparison of live organism shedding between mice infected intragastrically with Chlamydia muridarum with or without plasmid. Groups of C57BL/6J (C57) mice (n = 4 to 6) inoculated intragastrically with C. muridarum with (plasmid positive) (a to d) or without (plasmid deficient) (e to h) plasmid were monitored for live chlamydial organism shedding in rectal swabs on days 3 and 7 and weekly thereafter, as indicated along the x axis. Different inoculation doses ranging from 103 to 106 inclusion forming units (IFU) per mouse were used for different groups of mice as indicated on the right, while the live organisms recovered from rectal swabs are expressed as log10 IFU as shown along the left y axis.

Plasmid is critical for promoting chlamydial colonization in the small intestine.To evaluate the role of the plasmid in improving chlamydial fitness in the small intestine, we first compared the yields of infectious organisms harvested from different GI tract tissues of mice intragastrically inoculated with Chlamydia with or without plasmid (Fig. 2). Infectious plasmid-positive Chlamydia was readily detected in all tissues throughout the GI tract but was gradually restricted to the large intestinal tissues by day 28. This tissue distribution pattern is consistent with what we reported previously (38). However, to our surprise, no infectious plasmid-deficient Chlamydia was detected in the small intestine during the entire course of the experiment, although chlamydial genomes were detectable throughout the GI tract (Fig. 3). The chlamydial genome copies increased over time, suggesting that chlamydial genomes were able to proliferate in the small intestine. By day 14 after inoculation (when live plasmid-deficient chlamydial organisms were detected in the rectal swabs) (see Fig. 1), the large intestine became positive for infectious organisms, and the number of large intestinal infectious organisms increased over time (Fig. 2), indicating that plasmid-deficient chlamydial organisms were able to produce infectious progenies in large intestine. Thus, in the absence of plasmid, chlamydial organisms were inhibited from producing infectious progenies only in small intestine. The question is, what host effectors are responsible for the suppression?

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2

Comparison of live organism recovery from gastrointestinal tissues between mice inoculated intragastrically with Chlamydia muridarum with or without plasmid. Groups of C57 mice (n = 3 to 5) intragastrically inoculated with 1 × 105 IFU of Chlamydia muridarum with (plasmid positive) (a to e) or without (plasmid deficient) (f to j) plasmid were sacrificed to quantitate live chlamydial organism recovery in different regions of gastrointestinal tract as shown along the x axis on days 3 and 7 and weekly thereafter, as indicated on the right. The live organisms recovered from different tissues are expressed as log10 IFU as shown along the left y axis.

FIG 3
  • Open in new tab
  • Download powerpoint
FIG 3

Chlamydial genome copies recovered from gastrointestinal tissues of mice inoculated intragastrically with plasmid-deficient Chlamydia. Groups of C57 mice (n = 3 to 5) intragastrically inoculated with 1 × 105 IFU of plasmid-deficient Chlamydia muridarum (as described in the legend for Fig. 2) were sacrificed to quantitate chlamydial genome copies in different regions of gastrointestinal tract as shown along the x axis on days 3 (a) and 7 (b) and weekly thereafter (c to e), as indicated on the right. The genome copies recovered from different tissues are expressed as log10 genomes per tissue as shown along the y axis.

To evaluate the role of small intestinal effectors in regulating plasmid-free Chlamydia colonization in the small intestine without interference from gastric effectors, we used an intrajejunal inoculation to bypass the gastric barrier (Fig. 4). We found that following intrajejunal inoculation, live plasmid-deficient chlamydial organisms were recovered from the small intestine, suggesting that the small intestinal noninfectious status of the plasmid-deficient chlamydial organisms developed following intragastric inoculation was caused by a combination of gastric and small effectors. Nevertheless, following intrajejunal inoculation, the plasmid deficiency increased the 50% infective dose (ID50) by ∼530-fold. Careful analyses further revealed that plasmid-positive Chlamydia maintained similar ID50s in both jejunum and colon following an intrajejunal inoculation, suggesting that most live plasmid-positive organisms recovered from jejunum tissue may have spread to the large intestine. However, plasmid-deficient Chlamydia increased its ID50 by ∼3-fold in the colon, implying that only one-third of the live plasmid-deficient organisms successfully spread from jejunum to the colon.

FIG 4
  • Open in new tab
  • Download powerpoint
FIG 4

Comparison of live organism recovery from gastrointestinal tissues between mice infected via intrajejunal inoculation with Chlamydia muridarum with or without plasmid. Groups of C57 mice (n = 3 to 5) infected via intrajejunal inoculation with different doses (as shown in individual panels) of C. muridarum with (plasmid positive) (a to d) or without (plasmid free) (e to h) plasmid were sacrificed to quantitate live chlamydial organism recoveries in different regions of gastrointestinal tract as shown along the x axis on day 3 after intrajejunal inoculation. The live organisms recovered from different tissues are expressed as log10 IFU as shown along the left y axis. The doses required for infecting 50% of mice (ID50) were calculated for samples collected from jejunum and colon and are listed at the bottom (below the corresponding samples).

Plasmid promotes chlamydial adaptation in large intestine.To evaluate the role of the plasmid in chlamydial colonization in the colon, we used an intracolon inoculation (Fig. 5). We found that the infectious yields of plasmid-positive Chlamydia were significantly higher than those of plasmid-deficient Chlamydia, suggesting that plasmid may also promote chlamydial colonization in the large intestine. We further observed that upon intracolon inoculation, plasmid-positive Chlamydia was able to rapidly establish stable colonization starting from day 3, while plasmid-deficient Chlamydia started with a very low titer of infectious particles on day 3 and a very high titer on day 7 followed by a rapid decline in titer on day 14. The titers became relatively stable thereafter. These observations suggest that the plasmid may speed up chlamydial adaptation to the colonic environment. Nevertheless, despite these differences, both types of organisms maintained long-lasting colonization, up to 63 days. To further obtain quantitative data, we titrated the live organism recoveries from mice intracolonically inoculated with different amounts of chlamydial organisms (Fig. 6). We found that intracolon inoculation of 100 IFU was sufficient for plasmid-positive Chlamydia to establish stable colonization, while 1,000 IFU was required for plasmid-deficient Chlamydia to do so. More interestingly, plasmid-positive Chlamydia reduced its ID50s by ∼20-fold over time after intracolon inoculation (there was a transient ID50 reduction by ∼70-fold on day 7 only), suggesting that plasmid-positive Chlamydia is able to improve its colonization over time by adapting to the large intestine environment. However, plasmid-deficient Chlamydia maintained similar levels of ID50s throughout the time course despite a transient reduction on day 7, suggesting that in the absence of the plasmid, chlamydial organisms were unable to improve their colonization in the large intestine over time.

FIG 5
  • Open in new tab
  • Download powerpoint
FIG 5

Comparison of live organism shedding between mice infected via intracolon inoculation with Chlamydia muridarum with or without plasmid. Groups of C57 mice (n = 4 to 6) inoculated via intracolon inoculation with 1 × 105 IFU of C. muridarum with (plasmid positive) (a) or without (plasmid deficient) (b) plasmid were monitored for live chlamydial organism shedding in rectal swabs on days 3 and 7 and weekly thereafter, as indicated along x axis. The live organisms recovered from rectal swabs are expressed as log10 IFU, as shown along the y axis. The level of colonization by plasmid-deficient Chlamydia was significantly lower than that of plasmid-positive Chlamydia (area under curve, Wilcoxon rank sum, P < 0.05).

FIG 6
  • Open in new tab
  • Download powerpoint
FIG 6

Comparison of live organism recovery from rectal swabs between mice infected via intracolon inoculation with Chlamydia muridarum with or without plasmid. Groups of C57 mice (n = 3 to 5) infected via intracolon inoculation with different doses (as shown in individual panels) of C. muridarum with (plasmid positive) (a to d) or without (plasmid deficient) (e to h) plasmid were monitored for live chlamydial organism recovery in rectal swabs on days 3 and 7 and weekly thereafter after intracolon inoculation (as shown along x axis). The live organisms recovered are expressed as log10 IFU, as shown along the y axis. The doses required for infecting 50% of the mice (ID50) were calculated for samples collected at individual time points and are listed at the bottom (below the corresponding time points).

DISCUSSION

Chlamydia is frequently detected in the GI tracts of both animals and humans (33–36, 38, 53–55). However, the mechanisms by which Chlamydia colonizes the gut remain unknown. Although C. muridarum plasmid is a known pathogenic determinant in the genital tract, it is more important for C. muridarum to colonize GI tract than genital tract (45), suggesting that the plasmid might have been acquired by C. muridarum to improve its fitness in the GI tract. Here, we have used C. muridarum colonization in the mouse GI tract as a model to reveal the roles of the cryptic plasmid in promoting chlamydial colonization in distinct regions of the GI tract. By using a combination of intragastric, intrajejunal, and intracolon inoculations, we have demonstrated a critical role of the plasmid in improving chlamydial colonization in multiple regions of the GI tract. First, following an intragastric inoculation, the plasmid improved chlamydial colonization efficiency by >100-fold, since it took an inoculum dose of 105 IFU of plasmid-deficient Chlamydia to achieve stable colonization in the GI tract, while 1,000 IFU of plasmid-positive Chlamydia was able to do so. Second, when live organisms from individual mouse GI tract tissues were compared, we found that no live plasmid-deficient chlamydial organisms were recovered from small intestine, although live organisms were detected in the large intestines of the same mice on day 14 after intragastric inoculation, suggesting a requirement of the plasmid for chlamydial organisms to produce infectious progenies in the small intestine. Third, following an intrajejunal inoculation, infectious particles of plasmid-deficient Chlamydia were recovered from the small intestine but were ∼530-fold less infectious than those of plasmid-positive Chlamydia, indicating a critical role of the plasmid in chlamydial resistance to small intestinal effectors. Finally, the plasmid also played an important role in chlamydial adaptation to the large intestine. It took 10-fold more plasmid-deficient Chlamydia organisms than plasmid-positive Chlamydia organisms to achieve long-lasting colonization following intracolon inoculation. Furthermore, plasmid-positive Chlamydia improved colonization efficiency over time following intracolon inoculation, while plasmid-deficient Chlamydia failed to do so. Thus, the plasmid is able to improve chlamydial fitness in all regions of the GI tract but with the most significant role in the small intestine. Since different regions of the GI tract are equipped with different immune effectors (50–52) and the role of plasmid in improving chlamydial colonization in different regions varies considerably in terms of quantity and time kinetics, we propose that Chlamydia may have acquired the cryptic plasmid to improve its fitness in different regions of GI tract via different mechanisms. The fact that the plasmid both harbors 8 different genes and regulates two dozen chromosomal genes (56) suggests that the plasmid may have the capacity to do so. The present study has laid a foundation to further reveal the specific mechanisms by which different plasmid-dependent factors interact with different host effectors in different regions of the GI tract.

The finding that no infectious particles were ever recovered from small intestinal tissues of mice intragastrically inoculated with plasmid-deficient Chlamydia was a surprise to us. Nevertheless, plasmid-deficient chlamydial genomes were recovered from the same tissues, and the number of chlamydial genomes increased over time, suggesting that the plasmid-deficient chlamydial organisms were live but not infectious in the small intestine. This status is similar to that with persistent infection. C. muridarum can be induced to undergo persistence (57, 58). Both gastric and small intestinal effectors might contribute to the induction of plasmid-deficient Chlamydia into persistent infection in the small intestine, since a direct inoculation of plasmid-deficient Chlamydia into jejunum led to recovery of infectious particles. We have recently shown that the plasmid-encoded pGP3 plays an important role in promoting chlamydial survival in the stomach by resisting gastric acid (49). In the absence of plasmid, chlamydial organisms may use persistence as an alternative strategy for dealing with gastric acid stress. The chlamydial chromosome does carry acid stress response genes (59). It will be interesting to investigate how gastric and small intestinal effectors trigger and maintain chlamydial persistence. Regardless of how the noninfectious status was induced, this small intestinal infection condition may provide an ideal in vivo model for investigating the mechanism and evaluating the biological significance of chlamydial persistence.

A second surprising finding from the present study is that the cryptic plasmid is more important in promoting chlamydial colonization in the small intestine than in the large intestine. This conclusion is supported by the series of experiments that used quantitative comparison of plasmid-positive versus plasmid-deficient Chlamydia for colonizing small versus large intestinal tissues. Following intragastric or intrajejunal inoculation with plasmid-deficient Chlamydia, no or 530-fold fewer infectious organisms were recovered from the small intestine. However, when the same organisms were intracolonically inoculated, plasmid-deficient Chlamydia was only 7- to 120-fold less capable of establishing colonization. This difference may be caused by both different growth advantages of plasmid-positive versus -deficient Chlamydia and different effectors in small versus large intestines. Plasmid-deficient C. muridarum is known to be less efficient than plasmid-positive C. muridarum in colonizing mouse genital tract tissues, although both organisms can establish robust colonization (16). Thus, the reduced growth advantage by plasmid-deficient Chlamydia may contribute to its deficient colonization in different intestinal tissues. However, the different infectious particle recoveries of the same plasmid-deficient Chlamydia strain from small versus large intestines may be regulated by different intestinal effectors. For example, the small intestinal effectors might be able to drive chlamydial persistence, while large intestinal effectors failed to do so. It is worth noting that we have recently shown that C. muridarum can spread via the hematogenous route (41), which partially explains why when C. muridarum was introduced to mouse mucosae, it readily colonized the GI tract (37). Thus, chlamydial organisms inoculated into different regions of the GI tract may spread across the GI tract via a hematogenous route in addition to the lumenal spreading discussed above. It is worth differentiating the contribution of hematogenous spreading from that of lumenal spreading.

MATERIALS AND METHODS

Chlamydia muridarum organisms.Chlamydia muridarum strain Nigg3 was propagated and purified in HeLa cells (ATCC catalog number CCL2 [60]). Nigg3 genome sequence (GenBank accession CP009760.1) is different from that of the reference C. muridarum (26). Nigg3 was also used to derive a plasmid-deficient clone (designated CMUT3.G5 [13, 32]). Both Nigg3 (designated plasmid positive) and plasmid-deficient CMUT3.G5 were purified as elementary bodies (EBs) and stored in aliquots of SPG buffer (0.2 M sucrose, 20 mM sodium phosphate [pH 7.4], and 5 mM glutamic acid) at −80°C.

Mouse infection.All animal experiments were carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Laboratory Animal Experiments of the University of Texas Health Science Center at San Antonio.

Six- to seven-week-old female C57BL/6J (stock number 000664; Jackson Laboratories, Inc., Bar Harbor, ME) mice were inoculated with purified C. muridarum EBs at different doses (measured in inclusion-forming units [IFU]) via different routes as indicated for individual experiments. After inoculation, mice were monitored for rectal shedding of live organisms or sacrificed for monitoring live organisms or chlamydial genomes in different tissues at designated time points after infection as indicated for individual experiments. The oral or intragastric inoculation was carried out by intragastric intubation of chlamydial organisms in a total volume of 200 μl SPG buffer using a straight ball-tipped needle (N-PK 020; Braintree Scientific, Inc., Braintree, MA) as described previously (48). Intrajejunal inoculation was carried out as described previously (61, 62). Briefly, mice anesthetized with isoflurane underwent laparotomy (0.5-cm incision). Chlamydial organisms in a total volume of 50 μl SPG buffer were injected into the middle region of jejunum lumen with a 27-gauge needle. The jejunum middle region was identified and pulled closer to the abdominal wall to aid the injection by using curved forceps. After gently pulling out the needle, the jejunum was returned to the abdominal cavity, and the abdominal wall was closed with two or three 9-mm autoclips using an autoclip applier (both from Braintree Scientific, Inc.). For intracolon inoculation, chlamydial organisms were diluted in 50 μl of SPG buffer containing the desired number of IFU as indicated for individual experiments and delivered to the colon using a straight ball-tipped needle designed for mouse oral gavage (N-PK 020; Braintree Scientific, Inc.). After inoculation, mice were monitored for rectal live organism shedding or sacrificed to titrate live organisms in corresponding samples.

Titrating live chlamydial organisms recovered from rectal swabs and tissues.To quantitate live chlamydial organisms in rectal swabs, each swab was vortexed with glass beads in 0.5 ml of SPG buffer. For the titrating of live chlamydial organisms recovered from mouse tissues, different GI tract tissues were harvested on designated days after inoculation as specified for individual experiments. Each tissue segment was transferred to a vial containing 2 ml cold SPG buffer including stomach (Sto), duodenum (Duo), jejunum (Jej), ileum (Ile), cecum (Cec), colon (Col), or anorectum (Rec) for homogenization and sonication (63). The chlamydial organisms released into the supernatants were titrated on HeLa cell monolayers in duplicates and counted using an immunofluorescence assay (64). The total number of IFU per swab was calculated based on the mean IFU per view, the ratio of the view area to that of the well, dilution factor, and inoculation volumes. Where possible, a mean IFU/swab was derived from the serially diluted samples for any given swab. The total numbers of IFU/swab were converted into log10 for calculating group means and standard deviations.

Titrating the number of C. muridarum genomes in mouse tissues using quantitative PCR.To quantitate the genome copies of C. muridarum in a given tissue sample, 200 μl of each tissue homogenate prepared as described above (prior to sonication) was transferred to a lysis buffer provided with the Quick-gDNA miniprep kit (catalog number 11-317C; Genesee Scientific, San Diego, CA) for DNA extraction according to the manufacturer’s instructions. Each DNA preparation was eluted in 100 μl elution buffer, and 2 μl was used for quantitative PCR (qPCR). The following primers derived from the chlamydial 16S rRNA coding region were used: forward primer (5′-CGCCTGAGGAGTACACTCGCAGGA-3), reverse primer (5′-CCAACACCTCACGGCACGAG-3′), and double-quenched probe (5′-CACAAGCAGTGGAGCATGTGGTTTAA-3′) (Integrated DNA Technologies, Coralville, IA). PCRs were carried out in a total volume of 10 μl in a CFX96 Touch deep-well real-time PCR Detection system with IQ Supermix real-time PCR reagent (Bio-Rad, Hercules, CA). The qPCR conditions included an initial denaturation step at 95°C for 3 min, followed by 40 cycles of amplification at 95°C for 15 s and 60°C for 1 min. Genome copy numbers from a given sample in triplicates were calculated based on a standard plasmid DNA and expressed as log10 genomes per sample.

Statistics analyses.The numbers of live organisms (in IFU) and genome copies either at individual data points or over a time course were compared using Wilcoxon rank sum test. Areas under the curves (AUCs) were used for comparing time course data. The 50% infection dose (ID50) was calculated using the IC50 calculator from AAT Bioquest (https://www.aatbio.com/tools/ic50-calculator/) based on IFU positivity in mouse samples (49).

ACKNOWLEDGMENTS

This work was supported in part by grants (to G. Zhong) from the U.S. National Institutes of Health. J.M. is supported by the Tianjin Medical University General Hospital.

FOOTNOTES

    • Received 9 November 2019.
    • Returned for modification 25 November 2019.
    • Accepted 20 December 2019.
    • Accepted manuscript posted online 23 December 2019.
  • Copyright © 2020 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Budrys NM,
    2. Gong S,
    3. Rodgers AK,
    4. Wang J,
    5. Louden C,
    6. Shain R,
    7. Schenken RS,
    8. Zhong G
    . 2012. Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection. Obstet Gynecol 119:1009–1016. doi:10.1097/AOG.0b013e3182519326.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Rodgers AK,
    2. Budrys NM,
    3. Gong S,
    4. Wang J,
    5. Holden A,
    6. Schenken RS,
    7. Zhong G
    . 2011. Genome-wide identification of Chlamydia trachomatis antigens associated with tubal factor infertility. Fertil Steril 96:715–721. doi:10.1016/j.fertnstert.2011.06.021.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Rodgers AK,
    2. Wang J,
    3. Zhang Y,
    4. Holden A,
    5. Berryhill B,
    6. Budrys NM,
    7. Schenken RS,
    8. Zhong G
    . 2010. Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatis caseinolytic protease P. Am J Obstet Gynecol 203:494.e7–494.e14. doi:10.1016/j.ajog.2010.06.005.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Vlcek KR,
    2. Li W,
    3. Manam S,
    4. Zanotti B,
    5. Nicholson BJ,
    6. Ramsey KH,
    7. Murthy AK
    . 2016. The contribution of Chlamydia-specific CD8+ T cells to upper genital tract pathology. Immunol Cell Biol 94:208–212. doi:10.1038/icb.2015.74.
    OpenUrlCrossRef
  5. 5.↵
    1. de la Maza LM,
    2. Peterson EM
    . 2002. Vaccines for Chlamydia trachomatis infections. Curr Opin Invest Drugs 3:980–986.
    OpenUrlPubMed
  6. 6.↵
    1. Morrison RP,
    2. Caldwell HD
    . 2002. Immunity to murine chlamydial genital infection. Infect Immun 70:2741–2751. doi:10.1128/iai.70.6.2741-2751.2002.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Lu C,
    2. Peng B,
    3. Li Z,
    4. Lei L,
    5. Li Z,
    6. Chen L,
    7. He Q,
    8. Zhong G,
    9. Wu Y
    . 2013. Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator. Microbes Infect 15:329–338. doi:10.1016/j.micinf.2013.02.001.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Johnson RM,
    2. Kerr MS,
    3. Slaven JE
    . 2014. An atypical CD8 T-cell response to Chlamydia muridarum genital tract infections includes T cells that produce interleukin-13. Immunology 142:248–257. doi:10.1111/imm.12248.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Rockey DD,
    2. Wang J,
    3. Lei L,
    4. Zhong G
    . 2009. Chlamydia vaccine candidates and tools for chlamydial antigen discovery. Expert Rev Vaccines 8:1365–1377. doi:10.1586/erv.09.98.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Shah AA,
    2. Schripsema JH,
    3. Imtiaz MT,
    4. Sigar IM,
    5. Kasimos J,
    6. Matos PG,
    7. Inouye S,
    8. Ramsey KH
    . 2005. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm Dis 32:49–56. doi:10.1097/01.olq.0000148299.14513.11.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. de la Maza LM,
    2. Pal S,
    3. Khamesipour A,
    4. Peterson EM
    . 1994. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 62:2094–2097.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Chen J,
    2. Zhang H,
    3. Zhou Z,
    4. Yang Z,
    5. Ding Y,
    6. Zhou Z,
    7. Zhong E,
    8. Arulanandam B,
    9. Baseman J,
    10. Zhong G
    . 2014. Chlamydial induction of hydrosalpinx in 11 strains of mice reveals multiple host mechanisms for preventing upper genital tract pathology. PLoS One 9:e95076. doi:10.1371/journal.pone.0095076.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Liu Y,
    2. Huang Y,
    3. Yang Z,
    4. Sun Y,
    5. Gong S,
    6. Hou S,
    7. Chen C,
    8. Li Z,
    9. Liu Q,
    10. Wu Y,
    11. Baseman J,
    12. Zhong G
    . 2014. Plasmid-encoded Pgp3 is a major virulence factor for Chlamydia muridarum to induce hydrosalpinx in mice. Infect Immun 82:5327–5335. doi:10.1128/IAI.02576-14.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Chen C,
    2. Zhou Z,
    3. Conrad T,
    4. Yang Z,
    5. Dai J,
    6. Li Z,
    7. Wu Y,
    8. Zhong G
    . 2015. In vitro passage selects for Chlamydia muridarum with enhanced infectivity in cultured cells but attenuated pathogenicity in mouse upper genital tract. Infect Immun 83:1881–1892. doi:10.1128/IAI.03158-14.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Conrad TA,
    2. Gong S,
    3. Yang Z,
    4. Matulich P,
    5. Keck J,
    6. Beltrami N,
    7. Chen C,
    8. Zhou Z,
    9. Dai J,
    10. Zhong G
    . 2016. The chromosome-encoded hypothetical protein TC0668 is an upper genital tract pathogenicity factor of Chlamydia muridarum. Infect Immun 84:467–479. doi:10.1128/IAI.01171-15.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Lei L,
    2. Chen J,
    3. Hou S,
    4. Ding Y,
    5. Yang Z,
    6. Zeng H,
    7. Baseman J,
    8. Zhong G
    . 2014. Reduced live organism recovery and lack of hydrosalpinx in mice infected with plasmid-free Chlamydia muridarum. Infect Immun 82:983–992. doi:10.1128/IAI.01543-13.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. O'Connell CM,
    2. Ingalls RR,
    3. Andrews CW,
    4. Scurlock AM,
    5. Darville T
    . 2007. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J Immunol 179:4027–4034. doi:10.4049/jimmunol.179.6.4027.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Cheng W,
    2. Shivshankar P,
    3. Li Z,
    4. Chen L,
    5. Yeh IT,
    6. Zhong G
    . 2008. Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun 76:515–522. doi:10.1128/IAI.01064-07.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Chen L,
    2. Cheng W,
    3. Shivshankar P,
    4. Lei L,
    5. Zhang X,
    6. Wu Y,
    7. Yeh IT,
    8. Zhong G
    . 2009. Distinct roles of CD28- and CD40 ligand-mediated costimulation in the development of protective immunity and pathology during Chlamydia muridarum urogenital infection in mice. Infect Immun 77:3080–3089. doi:10.1128/IAI.00611-08.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Chen L,
    2. Lei L,
    3. Chang X,
    4. Li Z,
    5. Lu C,
    6. Zhang X,
    7. Wu Y,
    8. Yeh IT,
    9. Zhong G
    . 2010. Mice deficient in MyD88 develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection. J Immunol 184:2602–2610. doi:10.4049/jimmunol.0901593.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Dai J,
    2. Tang L,
    3. Chen J,
    4. Yu P,
    5. Chen Z,
    6. Zhong G
    . 2016. The p47phox deficiency significantly attenuates the pathogenicity of Chlamydia muridarum in the mouse oviduct but not uterine tissues. Microbes Infect 18:190–198. doi:10.1016/j.micinf.2015.11.003.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Murthy AK,
    2. Li W,
    3. Chaganty BK,
    4. Kamalakaran S,
    5. Guentzel MN,
    6. Seshu J,
    7. Forsthuber TG,
    8. Zhong G,
    9. Arulanandam BP
    . 2011. Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect Immun 79:2928–2935. doi:10.1128/IAI.05022-11.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Yang Z,
    2. Conrad T,
    3. Zhou Z,
    4. Chen J,
    5. Dutow P,
    6. Klos A,
    7. Zhong G
    . 2014. Complement factor C5 but not C3 contributes significantly to hydrosalpinx development in mice infected with Chlamydia muridarum. Infect Immun 82:3154–3163. doi:10.1128/IAI.01833-14.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Manam S,
    2. Nicholson BJ,
    3. Murthy AK
    . 2013. OT-1 mice display minimal upper genital tract pathology following primary intravaginal Chlamydia muridarum infection. Pathog Dis 67:221–224. doi:10.1111/2049-632X.12032.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Thomas NS,
    2. Lusher M,
    3. Storey CC,
    4. Clarke IN
    . 1997. Plasmid diversity in Chlamydia. Microbiology 143:1847–1854. doi:10.1099/00221287-143-6-1847.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Read TD,
    2. Brunham RC,
    3. Shen C,
    4. Gill SR,
    5. Heidelberg JF,
    6. White O,
    7. Hickey EK,
    8. Peterson J,
    9. Utterback T,
    10. Berry K,
    11. Bass S,
    12. Linher K,
    13. Weidman J,
    14. Khouri H,
    15. Craven B,
    16. Bowman C,
    17. Dodson R,
    18. Gwinn M,
    19. Nelson W,
    20. DeBoy R,
    21. Kolonay J,
    22. McClarty G,
    23. Salzberg SL,
    24. Eisen J,
    25. Fraser CM
    . 2000. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 28:1397–1406. doi:10.1093/nar/28.6.1397.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Huang Y,
    2. Zhang Q,
    3. Yang Z,
    4. Conrad T,
    5. Liu Y,
    6. Zhong G
    . 2015. Plasmid-encoded Pgp5 is a significant contributor to Chlamydia muridarum induction of hydrosalpinx. PLoS One 10:e0124840. doi:10.1371/journal.pone.0124840.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Zhong G
    . 2017. Chlamydial plasmid-dependent pathogenicity. Trends Microbiol 25:141–152. doi:10.1016/j.tim.2016.09.006.
    OpenUrlCrossRef
  29. 29.↵
    1. Li Z,
    2. Chen D,
    3. Zhong Y,
    4. Wang S,
    5. Zhong G
    . 2008. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun 76:3415–3428. doi:10.1128/IAI.01377-07.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Song L,
    2. Carlson JH,
    3. Zhou B,
    4. Virtaneva K,
    5. Whitmire WM,
    6. Sturdevant GL,
    7. Porcella SF,
    8. McClarty G,
    9. Caldwell HD
    . 2014. Plasmid-mediated transformation tropism of chlamydial biovars. Pathog Dis 70:189–193. doi:10.1111/2049-632X.12104.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Gong S,
    2. Yang Z,
    3. Lei L,
    4. Shen L,
    5. Zhong G
    . 2013. Characterization of Chlamydia trachomatis plasmid-encoded open reading frames. J Bacteriol 195:3819–3826. doi:10.1128/JB.00511-13.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Liu Y,
    2. Chen C,
    3. Gong S,
    4. Hou S,
    5. Qi M,
    6. Liu Q,
    7. Baseman J,
    8. Zhong G
    . 2014. Transformation of Chlamydia muridarum reveals a role for Pgp5 in suppression of plasmid-dependent gene expression. J Bacteriol 196:989–998. doi:10.1128/JB.01161-13.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Peters RPH,
    2. Dubbink JH,
    3. van der Eem L,
    4. Verweij SP,
    5. Bos MLA,
    6. Ouburg S,
    7. Lewis DA,
    8. Struthers H,
    9. McIntyre JA,
    10. Morré SA
    . 2014. Cross-sectional study of genital, rectal, and pharyngeal chlamydia and gonorrhea in women in rural South Africa. Sex Transm Dis 41:564–569. doi:10.1097/OLQ.0000000000000175.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Gratrix J,
    2. Singh AE,
    3. Bergman J,
    4. Egan C,
    5. McGinnis J,
    6. Drews SJ,
    7. Read R
    . 2014. Prevalence and characteristics of rectal chlamydia and gonorrhea cases among men who have sex with men after the introduction of nucleic acid amplification test screening at 2 Canadian sexually transmitted infection clinics. Sex Transm Dis 41:589–591. doi:10.1097/OLQ.0000000000000176.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Gratrix J,
    2. Singh AE,
    3. Bergman J,
    4. Egan C,
    5. Plitt SS,
    6. McGinnis J,
    7. Bell CA,
    8. Drews SJ,
    9. Read R
    . 2015. Evidence for increased Chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics. Clin Infect Dis 60:398–404. doi:10.1093/cid/ciu831.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Musil K,
    2. Currie M,
    3. Sherley M,
    4. Martin S
    . 2016. Rectal chlamydia infection in women at high risk of chlamydia attending Canberra Sexual Health Centre. Int J STD AIDS 27:526–530. doi:10.1177/0956462415586317.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Perry LL,
    2. Hughes S
    . 1999. Chlamydial colonization of multiple mucosae following infection by any mucosal route. Infect Immun 67:3686–3689.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Zhang Q,
    2. Huang Y,
    3. Gong S,
    4. Yang Z,
    5. Sun X,
    6. Schenken R,
    7. Zhong G
    . 2015. In vivo and ex vivo imaging reveals a long-lasting chlamydial infection in the mouse gastrointestinal tract following genital tract inoculation. Infect Immun 83:3568–3577. doi:10.1128/IAI.00673-15.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Yeruva L,
    2. Melnyk S,
    3. Spencer N,
    4. Bowlin A,
    5. Rank RG
    . 2013. Differential susceptibilities to azithromycin treatment of chlamydial infection in the gastrointestinal tract and cervix. Antimicrob Agents Chemother 57:6290–6294. doi:10.1128/AAC.01405-13.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Yeruva L,
    2. Spencer N,
    3. Bowlin AK,
    4. Wang Y,
    5. Rank RG
    . 2013. Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. Pathog Dis 68:88–95. doi:10.1111/2049-632X.12052.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Dai J,
    2. Zhang T,
    3. Wang L,
    4. Shao L,
    5. Zhu C,
    6. Zhang Y,
    7. Failor C,
    8. Schenken R,
    9. Baseman J,
    10. He C,
    11. Zhong G
    . 2016. Intravenous inoculation with Chlamydia muridarum leads to a long-lasting infection restricted to the gastrointestinal tract. Infect Immun 84:2382–2388. doi:10.1128/IAI.00432-16.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Wang L,
    2. Zhang Q,
    3. Zhang T,
    4. Zhang Y,
    5. Zhu C,
    6. Sun X,
    7. Zhang N,
    8. Xue M,
    9. Zhong G
    . 2016. The Chlamydia muridarum organisms fail to auto-inoculate the mouse genital tract after colonization in the gastrointestinal tract for 70 days. PLoS One 11:e0155880. doi:10.1371/journal.pone.0155880.
    OpenUrlCrossRef
  43. 43.↵
    1. Wang L,
    2. Zhu C,
    3. Zhang T,
    4. Tian Q,
    5. Zhang N,
    6. Morrison S,
    7. Morrison R,
    8. Xue M,
    9. Zhong G
    . 2018. Nonpathogenic colonization with Chlamydia in the gastrointestinal tract as oral vaccination for inducing transmucosal protection. Infect Immun 86:e00630-17. doi:10.1128/IAI.00630-17.
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    1. Zhong G
    . 2018. Chlamydia spreading from the genital tract to the gastrointestinal tract - a two-hit hypothesis. Trends Microbiol 26:611–623. doi:10.1016/j.tim.2017.12.002.
    OpenUrlCrossRef
  45. 45.↵
    1. Shao L,
    2. Melero J,
    3. Zhang N,
    4. Arulanandam B,
    5. Baseman J,
    6. Liu Q,
    7. Zhong G
    . 2017. The cryptic plasmid is more important for Chlamydia muridarum to colonize the mouse gastrointestinal tract than to infect the genital tract. PLoS One 12:e0177691. doi:10.1371/journal.pone.0177691.
    OpenUrlCrossRef
  46. 46.↵
    1. Shao L,
    2. Zhang T,
    3. Liu Q,
    4. Wang J,
    5. Zhong G
    . 2017. Chlamydia muridarum with mutations in chromosomal genes tc0237 and/or tc0668 is deficient in colonizing the mouse gastrointestinal tract. Infect Immun 85:e00321-17. doi:10.1128/IAI.00321-17.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Shao L,
    2. Zhang T,
    3. Melero J,
    4. Huang Y,
    5. Liu Y,
    6. Liu Q,
    7. He C,
    8. Nelson DE,
    9. Zhong G
    . 2018. The genital tract virulence factor pGP3 is essential for Chlamydia muridarum colonization in the gastrointestinal tract. Infect Immun 86:e00429-17. doi:10.1128/IAI.00429-17.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    1. Koprivsek JJ,
    2. Zhang T,
    3. Tian Q,
    4. He Y,
    5. Xu H,
    6. Xu Z,
    7. Zhong G
    . 2019. Distinct roles of chromosome- versus plasmid-encoded genital tract virulence factors in promoting Chlamydia muridarum colonization in the gastrointestinal tract. Infect Immun 87:e00265-19. doi:10.1128/IAI.00265-19.
    OpenUrlAbstract/FREE Full Text
  49. 49.↵
    1. Zhang T,
    2. Huo Z,
    3. Ma J,
    4. He C,
    5. Zhong G
    . 2019. The plasmid-encoded pGP3 promotes Chlamydia evasion of acidic barriers in both stomach and vagina. Infect Immun 87:e00844-18. doi:10.1128/IAI.00844-18.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Agace WW,
    2. McCoy KD
    . 2017. Regionalized development and maintenance of the intestinal adaptive immune landscape. Immunity 46:532–548. doi:10.1016/j.immuni.2017.04.004.
    OpenUrlCrossRef
  51. 51.↵
    1. Ahluwalia B,
    2. Magnusson MK,
    3. Ohman L
    . 2017. Mucosal immune system of the gastrointestinal tract: maintaining balance between the good and the bad. Scand J Gastroenterol 52:1185–1193. doi:10.1080/00365521.2017.1349173.
    OpenUrlCrossRef
  52. 52.↵
    1. Hama I,
    2. Tominaga K,
    3. Yamagiwa S,
    4. Setsu T,
    5. Kimura N,
    6. Kamimura H,
    7. Wakai T,
    8. Terai S
    . 2019. Different distribution of mucosal-associated invariant T cells within the human cecum and colon. Cent Eur J Immunol 44:75–83. doi:10.5114/ceji.2019.84020.
    OpenUrlCrossRef
  53. 53.↵
    1. Yang R,
    2. Jacobson C,
    3. Gardner G,
    4. Carmichael I,
    5. Campbell AJ,
    6. Ryan U
    . 2014. Longitudinal prevalence and faecal shedding of Chlamydia pecorum in sheep. Vet J 201:322–326. doi:10.1016/j.tvjl.2014.05.037.
    OpenUrlCrossRef
  54. 54.↵
    1. Pospischil A,
    2. Borel N,
    3. Chowdhury EH,
    4. Guscetti F
    . 2009. Aberrant chlamydial developmental forms in the gastrointestinal tract of pigs spontaneously and experimentally infected with Chlamydia suis. Vet Microbiol 135:147–156. doi:10.1016/j.vetmic.2008.09.035.
    OpenUrlCrossRefPubMed
  55. 55.↵
    1. Craig AP,
    2. Kong FY,
    3. Yeruva L,
    4. Hocking JS,
    5. Rank RG,
    6. Wilson DP,
    7. Donovan B
    . 2015. Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract. BMC Infect Dis 15:200. doi:10.1186/s12879-015-0939-3.
    OpenUrlCrossRefPubMed
  56. 56.↵
    1. Song L,
    2. Carlson JH,
    3. Whitmire WM,
    4. Kari L,
    5. Virtaneva K,
    6. Sturdevant DE,
    7. Watkins H,
    8. Zhou B,
    9. Sturdevant GL,
    10. Porcella SF,
    11. McClarty G,
    12. Caldwell HD
    . 2013. Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes. Infect Immun 81:636–644. doi:10.1128/IAI.01305-12.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    1. Carey AJ,
    2. Huston WM,
    3. Cunningham KA,
    4. Hafner LM,
    5. Timms P,
    6. Beagley KW
    . 2013. Characterization of in vitro Chlamydia muridarum persistence and utilization in an in vivo mouse model of Chlamydia vaccine. Am J Reprod Immunol 69:475–485. doi:10.1111/aji.12093.
    OpenUrlCrossRefPubMed
  58. 58.↵
    1. Gracey E,
    2. Lin A,
    3. Akram A,
    4. Chiu B,
    5. Inman RD
    . 2013. Intracellular survival and persistence of Chlamydia muridarum is determined by macrophage polarization. PLoS One 8:e69421. doi:10.1371/journal.pone.0069421.
    OpenUrlCrossRef
  59. 59.↵
    1. Bliven KA,
    2. Fisher DJ,
    3. Maurelli AT
    . 2012. Characterization of the activity and expression of arginine decarboxylase in human and animal Chlamydia pathogens. FEMS Microbiol Lett 337:140–146. doi:10.1111/1574-6968.12021.
    OpenUrlCrossRefPubMedWeb of Science
  60. 60.↵
    1. Fan T,
    2. Lu H,
    3. Hu H,
    4. Shi L,
    5. McClarty GA,
    6. Nance DM,
    7. Greenberg AH,
    8. Zhong G
    . 1998. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 187:487–496. doi:10.1084/jem.187.4.487.
    OpenUrlAbstract/FREE Full Text
  61. 61.↵
    1. Meitin CA,
    2. Bender BS,
    3. Small PA, Jr
    . 1994. Enteric immunization of mice against influenza with recombinant vaccinia. Proc Natl Acad Sci U S A 91:11187–11191. doi:10.1073/pnas.91.23.11187.
    OpenUrlAbstract/FREE Full Text
  62. 62.↵
    1. Etchart N,
    2. Wild F,
    3. Kaiserlian D
    . 1996. Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus. J Gen Virol 77:2471–2478. doi:10.1099/0022-1317-77-10-2471.
    OpenUrlCrossRefPubMedWeb of Science
  63. 63.↵
    1. Lin H,
    2. He C,
    3. Koprivsek JJ,
    4. Chen J,
    5. Zhou Z,
    6. Arulanandam B,
    7. Xu Z,
    8. Tang L,
    9. Zhong G
    . 2019. Antigen-specific CD4+ T cell-derived gamma interferon is both necessary and sufficient for clearing Chlamydia from the small intestine but not the large intestine. Infect Immun 87:e00055-19. doi:10.1128/IAI.00055-19.
    OpenUrlAbstract/FREE Full Text
  64. 64.↵
    1. Tang L,
    2. Zhang H,
    3. Lei L,
    4. Gong S,
    5. Zhou Z,
    6. Baseman J,
    7. Zhong G
    . 2013. Oviduct infection and hydrosalpinx in DBA1/j mice is induced by intracervical but not intravaginal inoculation with Chlamydia muridarum. PLoS One 8:e71649. doi:10.1371/journal.pone.0071649.
    OpenUrlCrossRef
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
The Cryptic Plasmid Improves Chlamydia Fitness in Different Regions of the Gastrointestinal Tract
Jingyue Ma, Conghui He, Zhi Huo, Ying Xu, Bernard Arulanandam, Quanzhong Liu, Guangming Zhong
Infection and Immunity Feb 2020, 88 (3) e00860-19; DOI: 10.1128/IAI.00860-19

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Cryptic Plasmid Improves Chlamydia Fitness in Different Regions of the Gastrointestinal Tract
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Cryptic Plasmid Improves Chlamydia Fitness in Different Regions of the Gastrointestinal Tract
Jingyue Ma, Conghui He, Zhi Huo, Ying Xu, Bernard Arulanandam, Quanzhong Liu, Guangming Zhong
Infection and Immunity Feb 2020, 88 (3) e00860-19; DOI: 10.1128/IAI.00860-19
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Chlamydia muridarum
plasmid
GI tract colonization
Chlamydia
gastrointestinal tract
persistence

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522